DELIVER Subanalysis 'Seals Deal' for Dapagliflozin in HF
An analysis of the large global DELIVER trial found that dapagliflozin improved outcomes and symptoms across a wide range of patients with heart failure.
Source: medscape.com
Page 37 - V Imaging News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from V Imaging. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In V Imaging Today - Breaking & Trending Today
Visceral Adiposity May Predict Mortality Risk in HFpEF
Regional adiposity is a potential marker for all-cause death in patients with heart failure with preserved ejection fraction (HFpEF), a new preprint suggests.
Source: medscape.com
Mandrola's Top 10 Cardiology Stories of 2022
A few dogmas felled, wins for meds, an exemplary trial, and clinical trends good and bad are covered in John Mandrola’s annual wrap up of cardiology stories for 2022.
Source: medscape.com
The Plaque Hypothesis: Focus on Vulnerable Lesions to Cut Events
A new strategy is needed targeting unstable plaque in the whole of the coronary arteries, rather than just obstructive lesions, to reduce major adverse cardiac events, a new review suggests.
Source: medscape.com
FDA Panel Votes No on Omecamtiv Mecarbil for Heart Failure
An FDA advisory committee voted 8 to 3 that the benefits of omecamtiv mecarbil do not outweigh its risks for the treatment of heart failure with reduced ejection fraction.
Source: medscape.com